Walton Centre NHS Foundation Trust
13
2
3
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
7.7%
1 terminated/withdrawn out of 13 trials
87.5%
+1.0% vs industry average
15%
2 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing
Role: lead
Understanding Cauda Equina Syndrome
Role: collaborator
Exercise Videos - Perspectives of People Living With Chronic Pain
Role: lead
Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage
Role: lead
Nerve Root Block in Spasticity
Role: lead
Awareness Detection and Communication in Disorders of Consciousness
Role: collaborator
MRI & QST Analysis in Trigeminal Neuralgia and Persistent Idiopathic Facial Pain
Role: lead
Repetitive Transcranial Magnetic Stimulation as a Treatment for Pain in Parkinson's Disease
Role: lead
Immune Profiles in Myasthenia Gravis
Role: collaborator
Clinical Response of Impulsivity After Brain Stimulation in Parkinson's Disease
Role: collaborator
Cognitive Behavioural Therapy Software for the Treatment of Depression in People With Multiple Sclerosis
Role: collaborator
Ketogenic Diets as an Adjuvant Therapy in Glioblastoma
Role: collaborator
A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis
Role: collaborator
All 13 trials loaded